載入...
Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) reported to show a higher efficacy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) than other TKIs. However, few studies describe ponatinib for pediatric Ph+ALL; therefore, the efficacy, safety, and opti...
Na minha lista:
| 發表在: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983555/ https://ncbi.nlm.nih.gov/pubmed/33776678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511071 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|